Entera Bio ENTX
NASDAQ ENTX
$2.86 -0.03 (-1.04%)
At close: Oct 2, 2026 · 4:00 PM EDT

Entera Bio (ENTX) Return on Capital Employed [ROCE] (2022 - 2026)

Updated

Entera Bio's Return on Capital Employed [ROCE] was -101.62% in Q2 2026, down 45.27 percentage points from -56.36% a year earlier and down 5.08 percentage points from the prior quarter.

Analysis

Entera Bio (ENTX) Return on Capital Employed [ROCE] (2022 - 2026) Analysis & Trends

For FY2025, Return on Capital Employed [ROCE] at Entera Bio came in at -109.92%, down 7.97 percentage points from FY2024.

  • Return on Capital Employed [ROCE] has now declined for three consecutive years, with a five-year change of -11.71 percentage points (FY2020 to FY2025).
  • In earlier years, Return on Capital Employed [ROCE] was -101.95% in FY2024 (-23.65 pp), -78.30% in FY2023 (-6.84 pp), -71.46% in FY2022 (+11.69 pp) and -83.15% in FY2021 (+15.06 pp).
  • The Q2 2026 figure marks the lowest quarterly Return on Capital Employed [ROCE] since Q4 2024.
  • Compared with a year earlier, Return on Capital Employed [ROCE] was higher in five of the last eight quarters, with an average year-over-year change of +9.44 percentage points.
  • The best year-over-year quarter for Return on Capital Employed [ROCE] over five years was Q3 2025 (a gain of 54.83 percentage points); the worst was Q3 2023 (a drop of 46.60 percentage points).
  • Per Business Quant data, ENTX's Return on Capital Employed [ROCE] in the three quarters before Q2 2026 was -96.54% (Q1 2026), -79.74% (Q4 2025) and -64.06% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 17.83%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 17.92%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 6.28%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 19.32%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.54%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 16.66%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -5.97%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.86%
10 Entera Bio 140.97 Mn 109.84 Mn - -101.62%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -101.62%
Mar 31, 2026 -96.54%
Dec 31, 2025 -79.74%
Sep 30, 2025 -64.06%
Jun 30, 2025 -56.36%
Mar 31, 2025 -72.96%
Dec 31, 2024 -130.18%
Sep 30, 2024 -118.89%
Jun 30, 2024 -97.38%
Mar 31, 2024 -88.46%
Dec 31, 2023 -97.98%
Sep 30, 2023 -133.67%
Jun 30, 2023 -114.35%
Mar 31, 2023 -104.80%
Dec 31, 2022 -100.19%
Sep 30, 2022 -87.07%
Jun 30, 2022 -75.72%
Mar 31, 2022 -62.86%
API Access

Entera Bio Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=ENTX&period=max&api_key=YOUR_API_KEY